ARTA
IONS icon

A.R.T. Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

A.R.T. Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,895
Closed -$636K – 1562
2019
Q2 		$636K Buy
+9,895
New +$699K 0.04% 644
2018
Q2 		– Sell
-43,570
Closed -$1.92M – 1589
2018
Q1 		$1.92M Sell
43,570
-22,200
-34% -$1.13M 0.08% 396
2017
Q4 		$3.31M Buy
+65,770
New +$3.61M 0.15% 197
2017
Q2 		– Sell
-27,100
Closed -$1.09M – 1553
2017
Q1 		$1.09M Buy
+27,100
New +$1.22M 0.05% 528
2016
Q2 		– Sell
-29,304
Closed -$1.19M – 1486
2016
Q1 		$1.19M Sell
29,304
-63,935
-69% -$2.6M 0.05% 514
2015
Q4 		$5.77M Sell
93,239
-46,144
-33% -$2.49M 0.27% 67
2015
Q3 		$5.63M Sell
139,383
-26,975
-16% -$1.4M 0.21% 112
2015
Q2 		$9.57M Buy
+166,358
New +$10.6M 0.32% 45
2014
Q2 		– Sell
-76,100
Closed -$3.29M – 1407
2014
Q1 		$3.29M Buy
+76,100
New +$3.69M 0.17% 144
2013
Q4 		– Sell
-88,968
Closed -$3.34M – 1374
2013
Q3 		$3.34M Sell
88,968
-111,953
-56% -$3.34M 0.18% 150
2013
Q2 		$5.4M Buy
+200,921
New +$4.27M 0.18% 166

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

A.R.T. Advisors's IONS Position: Q3 2019 in Review

A.R.T. Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 9,895 shares — an estimated $636K sold.

A.R.T. Advisors first reported a position in IONS in Q2 2013 and held it in 11 quarters. The position peaked at $9.57M in Q2 2015. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • A.R.T. Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 9,895 Ionis Pharmaceuticals shares in Q3 2019, an estimated $636K.
  • A.R.T. Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • A.R.T. Advisors's Ionis Pharmaceuticals position peaked at $9.57M in Q2 2015.
  • 369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.